论文部分内容阅读
[目的]了解复治涂阳肺结核患者的诱因及经济负担状况,减少慢性传染源产生,为结核病控制规划实施提供参考依据。[方法]对2005年1月至2007年12月登记在册的复治涂阳肺结核患者进行问卷调查分析。[结果]无收入或低收入者占79.5%(132/166),自费治疗者占79.5%(132/166),既往初治不规则用药是复发主要原因占39.2%(65/166),疗程中未见医生随访占85.5%(142/166),未接受过任何结核病健康知识教育者占27.2%(45/166);耐药检测:耐H者占69.6%(80/115),耐R占61.7%(71/115),同时耐H、R者占47.8%(55/115)。[结论]应加强治疗管理工作,提高质量,制定个性化治疗方案。
[Objective] To understand the incentive and economic burden of smear-positive pulmonary tuberculosis patients in retreatment and reduce the generation of chronic infection sources and provide reference for the implementation of tuberculosis control program. [Methods] A questionnaire survey of patients with smear positive pulmonary tuberculosis registered from January 2005 to December 2007 was conducted. [Results] 79.5% (132/166) had no income or low income, 79.5% (132/166) had self-paid treatment, and 39.2% (65/166) were the main causes of recurrent irregular treatment. The duration of treatment Among them, 85.5% (142/166) were non-doctor’s follow-up and 27.2% (45/166) did not receive education on TB health knowledge. Drug resistance test showed that resistance to H accounted for 69.6% (80/115) Accounting for 61.7% (71/115), while resistant to H, R accounted for 47.8% (55/115). [Conclusion] Treatment and management should be strengthened, quality should be improved, and personalized treatment plan should be formulated.